Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
36.26
-0.27 (-0.74%)
At close: Apr 28, 2026, 4:00 PM EDT
35.87
-0.39 (-1.06%)
After-hours: Apr 28, 2026, 7:39 PM EDT

Company Description

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions.

It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment.

In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation.

Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Bruker Corporation
Bruker logo
Country United States
Founded 1960
IPO Date Aug 4, 2000
Industry Medical Devices
Sector Healthcare
Employees 11,085
CEO Frank Laukien

Contact Details

Address:
40 Manning Road
Billerica, Massachusetts 01821
United States
Phone 978 663 3660
Website bruker.com

Stock Details

Ticker Symbol BRKR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001109354
CUSIP Number 116794108
ISIN Number US1167941087
Employer ID 04-3110160
SIC Code 3826

Key Executives

Name Position
Dr. Burkhard Prause Ph.D. President and Chief Executive Officer of Bruker Energy and Supercon Technologies, Inc.
Dr. Frank H. Laukien Ph.D. Chairman, Chief Executive Officer and President
Dr. Mark R. Munch Ph.D. Corporate Executive Vice President and President of Bruker Nano Group and Corporate
Juergen W. Srega President of Bruker CALID Group and Bruker Daltonics Division
Thomas M. Bures Chief Accounting Officer
J. Brent Alldredge J.D. Senior Vice President, General Counsel, Secretary and Global Head of Compliance

Latest SEC Filings

Date Type Title
Apr 28, 2026 8-K Current Report
Apr 15, 2026 144 Filing
Apr 10, 2026 ARS Filing
Apr 10, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 10, 2026 DEF 14A Other definitive proxy statements
Apr 10, 2026 8-K Current Report
Apr 1, 2026 8-K Current Report
Mar 26, 2026 SCHEDULE 13G/A Filing
Mar 13, 2026 144 Filing
Mar 6, 2026 SCHEDULE 13G/A Filing